Biogen Idec’s ALS drug Failed Final Clinical Trial

.

Biogen Idec’s ALS drug Failed Final Clinical Trial

As per reports, it has been recently revealed that Biogen Idec was unable to get through the last clinical trial of its ALS drug. Researchers have acknowledged the loss by saying that it was not only shocking but discouraging as well.

Dr. Robert Brown, who is an ALS researcher, was of the view that they have worked hard on the drug, but they failed a crucial test. However, this does not mean that no more research will take as the disease needs an effective treatment.

While talking about the last and final clinical trial, which could not attain success, Brown said that they had enrolled 943 people, who were suffering from amyotrophic lateral sclerosis. They were enrolled to test the efficacy of their once-promising dexpramipexole drug.

After carrying out the study, Brown said that they did not find any sort of benefit from the drug. And, then only, they decided to halt the programme. "While these results were not what we expected, we hope this data will provide a foundation for future ALS research", said Dr. Douglas Kerr, who is the director of neurodegeneration clinical research at Biogen.

The failure does not mark an end to the research, said Kerr, as they still have been working on it.

 


Latest News

Demand for Treasury’s Auction Weak as Traders Expect an Interest Hike this Year
Solar Impulse 2 Completes Its Historic Journey Round the World and Lands in Abu
Telecom Giant Verizon Buys Yahoo and Plans to Merge it with AOL Unit
Wild fire continues to spread in Santa Clarita area
Debbie Wasserman Schultz steps down as head of DNC
Chinese Currency Faces Increasing Pressure
Crude Futures Remain Close to Two Month Low as Over Supply Concerns Intensify
Reportedly Verizon is Expected to Acquire Yahoo for $4.8 Billion
China’s Economic Growth in the Second Quarter Remains Steady but not without a P
Several Former and Current Fox News Female Workers Talk about their Harassment E
Hillary Clinton picksTim Kaine as running mate
Jerry Brown